Home
RMD
RMD News

Latest ResMed Inc. (RMD) News on November 21, 2024

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

Zacks

a day ago

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

a day ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

Zacks

a day ago

Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System

Zacks

a day ago

ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System

BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX

Zacks

2 days ago

BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX

ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year

Investor's Business Daily

3 days ago

ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year

ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders

Simply Wall St.

3 days ago

ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders

Here's Why You Should Add RMD Stock to Your Portfolio Now

Zacks

6 days ago

Here's Why You Should Add RMD Stock to Your Portfolio Now

Nevro Stock May Gain on the CE Mark Certification for HFX iQ

Zacks

6 days ago

Nevro Stock May Gain on the CE Mark Certification for HFX iQ

Morningstar Research

7 days ago

Analyst Report: ResMed Inc.

Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock

Zacks

7 days ago

Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock

MYGN Stock Might Gain From SneakPeek Availability in Retail Stores

Zacks

7 days ago

MYGN Stock Might Gain From SneakPeek Availability in Retail Stores

Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness

Simply Wall St.

7 days ago

Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness

QGEN Collaborates With McGill University Centre: Stock to Gain?

Zacks

8 days ago

QGEN Collaborates With McGill University Centre: Stock to Gain?

Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

Zacks

8 days ago

Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

Argus Research

9 days ago

RMD: Raising target price to $260.00

INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up

Zacks

10 days ago

INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up

ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues

Zacks

10 days ago

ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues

Zacks.com featured highlights include Greenbrier, Walmart, Leidos, InterDigital and ResMed

Zacks

10 days ago

Zacks.com featured highlights include Greenbrier, Walmart, Leidos, InterDigital and ResMed

OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Zacks

13 days ago

OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract

Zacks

13 days ago

AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract

PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise

Zacks

13 days ago

PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise

5 Dividend Growth Stocks to Buy on Trump Win & Fed Rate Cut

Zacks

13 days ago

5 Dividend Growth Stocks to Buy on Trump Win & Fed Rate Cut

With 74% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backing

Simply Wall St.

13 days ago

With 74% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backing

CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised

Zacks

14 days ago

CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

Zacks

14 days ago

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

BDX Stock Gains Following Q4 Earnings Beat and Higher Margins

Zacks

14 days ago

BDX Stock Gains Following Q4 Earnings Beat and Higher Margins

Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall

Zacks

15 days ago

Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall

MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands

Zacks

15 days ago

MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands

Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Zacks

15 days ago

Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Argus Research

16 days ago

RMD: Raising target price to $258.00

ResMed Announces Participation in the UBS Global Healthcare Conference

GlobeNewswire

16 days ago

ResMed Announces Participation in the UBS Global Healthcare Conference

Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure

Zacks

16 days ago

Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

Zacks

16 days ago

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Zacks

16 days ago

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

17 days ago

Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

17 days ago

Here's Why ResMed (RMD) is a Strong Growth Stock

QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel

Zacks

17 days ago

QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel

BellRing Brands Inc. (BRBR) Hits Fresh High: Is There Still Room to Run?

Zacks

17 days ago

BellRing Brands Inc. (BRBR) Hits Fresh High: Is There Still Room to Run?

Should You Buy ResMed Inc. (NYSE:RMD) For Its Upcoming Dividend?

Simply Wall St.

18 days ago

Should You Buy ResMed Inc. (NYSE:RMD) For Its Upcoming Dividend?

Boston Scientific Stock Gains From Market Expansion, Innovation

Zacks

20 days ago

Boston Scientific Stock Gains From Market Expansion, Innovation

PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis

Zacks

20 days ago

PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis

Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market

Zacks

21 days ago

Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market

MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin

Zacks

21 days ago

MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket

Zacks

22 days ago

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket

DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up

Zacks

22 days ago

DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up

Investors Shouldn't Overlook ResMed's (NYSE:RMD) Impressive Returns On Capital

Simply Wall St.

22 days ago

Investors Shouldn't Overlook ResMed's (NYSE:RMD) Impressive Returns On Capital

Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock

Zacks

23 days ago

Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock

ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock

Zacks

23 days ago

ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock

Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down

Zacks

24 days ago

Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down

PHG vs. RMD: Which Stock Should Value Investors Buy Now?

Zacks

24 days ago

PHG vs. RMD: Which Stock Should Value Investors Buy Now?

Why ResMed (RMD) is a Top Momentum Stock for the Long-Term

Zacks

24 days ago

Why ResMed (RMD) is a Top Momentum Stock for the Long-Term

TFX Stock to Gain From Launch of New Vascular Access Devices in Canada

Zacks

24 days ago

TFX Stock to Gain From Launch of New Vascular Access Devices in Canada

ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run?

Zacks

24 days ago

ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run?

ResMed First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

a month ago

ResMed First Quarter 2025 Earnings: Beats Expectations

S&P 500 Giant Leads 5 Stocks Near Buy Points

Investor's Business Daily

a month ago

S&P 500 Giant Leads 5 Stocks Near Buy Points

Decoding ResMed Inc (RMD): A Strategic SWOT Insight

GuruFocus.com

a month ago

Decoding ResMed Inc (RMD): A Strategic SWOT Insight

Morningstar Research

a month ago

Analyst Report: ResMed Inc.

ResMed Breaks Out As GLP-1 Drugs And Big Tech Help Drive A Quarterly Beat

Investor's Business Daily

a month ago

ResMed Breaks Out As GLP-1 Drugs And Big Tech Help Drive A Quarterly Beat

MT Newswires

a month ago

RBC Capital Adjusts Price Target on ResMed to $232 From $224

MT Newswires

a month ago

JPMorgan Adjusts Price Target on ResMed to $270 From $240

MT Newswires

a month ago

Mizuho Adjusts Price Target on ResMed to $275 From $250

MT Newswires

a month ago

Baird Adjusts Price Target on ResMed to $283 From $280

MT Newswires

a month ago

Jefferies Adjusts Price Target on ResMed to $245 From $225

MT Newswires

a month ago

KeyBanc Adjusts Price Target on ResMed to $266 From $251

MT Newswires

a month ago

UBS Adjusts Price Target on ResMed to $250 From $225, Maintains Neutral Rating

My 3 Favorite Stocks to Buy Right Now

Motley Fool

a month ago

My 3 Favorite Stocks to Buy Right Now

ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand

Zacks

a month ago

ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand

Thomson Reuters StreetEvents

a month ago

Q1 2025 ResMed Inc Earnings Call

Zacks.com featured highlights Leidos, NetApp, ResMed, Trane Technologies and Travelers

Zacks

a month ago

Zacks.com featured highlights Leidos, NetApp, ResMed, Trane Technologies and Travelers

ResMed Inc (RMD) Q1 2025 Earnings Call Highlights: Strong Financial Performance Amid Global ...

GuruFocus.com

a month ago

ResMed Inc (RMD) Q1 2025 Earnings Call Highlights: Strong Financial Performance Amid Global ...

Morningstar Research

a month ago

Analyst Report: ResMed Inc.

ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a month ago

ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

ResMed (RMD) Surpasses Q1 Earnings and Revenue Estimates

Zacks

a month ago

ResMed (RMD) Surpasses Q1 Earnings and Revenue Estimates

ResMed Adds To Its Recent Sprint, Shrugging Off Worries Tied To Obesity Drugs

Investor's Business Daily

a month ago

ResMed Adds To Its Recent Sprint, Shrugging Off Worries Tied To Obesity Drugs

MT Newswires

a month ago

ResMed Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Dividend Maintained -- Shares Up After Hours

Associated Press Finance

a month ago

ResMed: Fiscal Q1 Earnings Snapshot

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025

GlobeNewswire

a month ago

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025

5 Top Dividend Stocks That Promise Substantial Growth

Zacks

a month ago

5 Top Dividend Stocks That Promise Substantial Growth

Is ResMed Inc. (NYSE:RMD) Trading At A 29% Discount?

Simply Wall St.

a month ago

Is ResMed Inc. (NYSE:RMD) Trading At A 29% Discount?

Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key Metrics

Zacks

a month ago

Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key Metrics

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

a month ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why

Zacks

a month ago

ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why

Is ResMed Stock a Smart Addition to Your Portfolio Right Now?

Zacks

a month ago

Is ResMed Stock a Smart Addition to Your Portfolio Right Now?

ResMed (RMD) Earnings Expected to Grow: Should You Buy?

Zacks

a month ago

ResMed (RMD) Earnings Expected to Grow: Should You Buy?

ResMed Insiders Sold US$16m Of Shares Suggesting Hesitancy

Simply Wall St.

a month ago

ResMed Insiders Sold US$16m Of Shares Suggesting Hesitancy

PHG or RMD: Which Is the Better Value Stock Right Now?

Zacks

a month ago

PHG or RMD: Which Is the Better Value Stock Right Now?

Argus Research

a month ago

RMD: Lowering target price to $248.00

Does ResMed (NYSE:RMD) Deserve A Spot On Your Watchlist?

Simply Wall St.

a month ago

Does ResMed (NYSE:RMD) Deserve A Spot On Your Watchlist?

5 Dividend Growth Stocks to Buy in Q4

Zacks

a month ago

5 Dividend Growth Stocks to Buy in Q4

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

GlobeNewswire

2 months ago

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

Zacks.com featured highlights Ferrari, Vertex, ResMed and Hubbel

Zacks

2 months ago

Zacks.com featured highlights Ferrari, Vertex, ResMed and Hubbel

ResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker.

Barrons.com

2 months ago

ResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker.

ResMed (RMD) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

2 months ago

ResMed (RMD) Upgraded to Buy: What Does It Mean for the Stock?

Scoop up These 4 GARP Stocks to Receive Handsome Returns

Zacks

2 months ago

Scoop up These 4 GARP Stocks to Receive Handsome Returns

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

RMD Stock Likely to Gain From Enhanced Digital Sleep Health Solutions

Zacks

2 months ago

RMD Stock Likely to Gain From Enhanced Digital Sleep Health Solutions

MT Newswires

2 months ago

Jefferies Raises Price Target on ResMed to $225 From $200, Maintains Hold Rating

MT Newswires

2 months ago

RBC Raises Price Target on ResMed to $224 From $206, Keeps Sector Perform Rating

ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns

GlobeNewswire

2 months ago

ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns

Share on Social Networks: